Can Playing Wind Instruments Affect Glaucoma?

Some wind instruments can temporarily increase pressure inside the eye during performance. For musicians with glaucoma or glaucoma risk factors, understanding how instrument type, breathing technique, and eye health interact may help protect long-term vision.

Here is what Musicians Need to Know About Eye Pressure, Technique, and Long-Term Vision, says Dr Shibal Bhartiya.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Dr. Shibal Bhartiya has published peer-reviewed research examining the relationship between glaucoma and musical instrument performance. The discussion in this article draws upon both published evidence and ongoing clinical interest in how lifestyle activities may influence intraocular pressure and optic nerve health.

Related publication: Eye-tunes: role of music in ophthalmology and vision sciences; Twenty four hour eye pressure monitoring


Music, Breathing, and Eye Health: An Overlooked Conversation

Most people think of glaucoma as a disease influenced by age, family history, eye pressure, and genetics. Few consider whether a lifelong hobby or profession could affect the eyes.

Yet musicians who play wind instruments generate substantial airflow and pressure during performance. Researchers have therefore explored whether playing certain instruments might temporarily increase intraocular pressure (IOP), the pressure inside the eye.

The answer is more nuanced than many headlines suggest.

While some wind instruments may be associated with transient rises in eye pressure by almost 10%, the effects vary depending on the instrument, the player, the technique used, and the individual’s underlying glaucoma risk.

Following publication, Professor Frank Gabriel Campos, Professor Emeritus of Trumpet at Ithaca College, provided valuable insights regarding brass performance technique and the distinction between efficient airflow support and Valsalva-like straining. This article has been written to reflect those nuances and to encourage a more technique-sensitive interpretation of the available evidence.


Why Eye Pressure Matters in Glaucoma

Glaucoma is a chronic optic nerve disease that often progresses silently. Elevated intraocular pressure is one of its most important risk factors.

What makes glaucoma challenging is that damage often develops gradually over years before noticeable symptoms appear.

Many patients continue to see well while subtle changes accumulate in peripheral vision, contrast sensitivity, dark adaptation, or visual processing.

This is why activities that may temporarily increase eye pressure have attracted scientific interest.


Do Wind Instruments Increase Eye Pressure?

Several studies have reported temporary increases in intraocular pressure while playing certain wind instruments.

Researchers believe this may occur because high-resistance instruments require forceful exhalation against resistance, generating pressure changes within the chest, neck, and head.

These physiological changes may influence:

  • Venous pressure
  • Blood flow dynamics
  • Intraocular pressure
  • Optic nerve perfusion

Importantly, temporary increases in eye pressure are not the same as glaucoma.

Most musicians who play wind instruments never develop glaucoma.

However, for individuals who already have glaucoma, ocular hypertension, suspicious optic nerves, or a strong family history, these findings may be clinically relevant.


Not All Instruments Are the Same

Different instruments create different airflow demands and resistance.

Instruments Often Associated with Higher Resistance

Instrument TypePotential Eye Pressure Concern
TrumpetHigher expiratory resistance
OboeVery high airflow resistance
French HornSustained pressure generation
BassoonHigh resistance airflow
Certain Brass InstrumentsRepeated pressure fluctuations

Instruments Generally Associated with Lower Resistance

Instrument TypeRelative Physiological Load
FluteLower resistance
ClarinetVariable
SaxophoneModerate
RecorderGenerally lower

The relationship remains complex and individual. In the Indian context, while there is little or no evidence, blowing the conch shell, and the flute may also have similar effects.


An Important Clarification About Technique

One of the most valuable insights on this topic comes not from ophthalmology, but from professional music performance.

After publication of an earlier version of this article, Professor Frank Gabriel Campos, Professor Emeritus of Trumpet at Ithaca College and author of Trumpet Technique (Oxford University Press), generously shared an important perspective.

Professor Campos notes that the Valsalva manoeuvre is generally considered poor or incorrect technique in high-level brass performance rather than a desired component of proper playing.

This distinction matters.

Some discussions of eye pressure and wind instruments assume that elevated pressure results from Valsalva-like straining. However, experienced musicians aim to support airflow efficiently without unnecessary glottic closure or excessive pressure generation.

In other words:

The physiological effects of wind instrument performance may depend not only on the instrument being played, but also on how it is played.

This highlights an important area for future research.

Understanding technique may prove just as important as understanding instrument type.

The author gratefully acknowledges Professor Frank Gabriel Campos for his thoughtful contribution to this discussion and for helping improve the accuracy and nuance of this article.


What Doctors May Miss

What Patients ThinkWhat May Actually Be Happening
“My vision seems normal.”Early glaucoma may cause no noticeable symptoms.
“Nobody asked about my hobbies.”Certain activities may provide useful risk information.
“My eye pressure is normal in clinic.”Eye pressure naturally fluctuates throughout the day.
“Playing music cannot affect my eyes.”Some instruments may temporarily influence eye pressure.
“Only family history matters.”Multiple risk factors interact in glaucoma development.
“If I see clearly, I must be safe.”Functional compensation can hide early disease.

Should Musicians Stop Playing?

In most cases, no.

The purpose of understanding these findings is not to discourage music.

For many musicians, playing an instrument is a profession, passion, social connection, and lifelong source of joy.

Instead, the goal is awareness.

If you have:

  • Glaucoma
  • Ocular hypertension
  • A strong family history of glaucoma
  • Suspicious optic nerves
  • Progressive visual field loss

it may be worth discussing your musical activities with your eye specialist.

Monitoring can often be tailored without requiring major lifestyle changes.


Questions Worth Asking Your Eye Doctor

  • Does my current glaucoma appear stable?
  • How advanced is my disease?
  • Should my eye pressure be monitored more closely?
  • Are there activities that may affect my individual risk profile?
  • Do my optic nerve findings suggest increased vulnerability?
  • Would additional testing be useful?

This page is a part of the Glaucoma Hub. you may want to read about Glaucoma Progression, and Risk Stratification in Glaucoma.


Frequently Asked Questions

Can playing a trumpet cause glaucoma?

No. Playing a trumpet does not directly cause glaucoma. However, some studies suggest that certain wind instruments may temporarily increase eye pressure during performance.

Is it safe to play a wind instrument if I have glaucoma?

Many people with glaucoma continue playing wind instruments safely. Decisions should be individualized based on disease severity, eye pressure control, and overall risk profile.

Which instruments are most often studied?

Trumpet, oboe, bassoon, and French horn have received particular attention because of their higher airflow resistance.

Does technique matter?

Yes. Professional musicians emphasize that efficient breathing and airflow support differ from excessive straining. Technique may influence physiological responses during performance.

Can normal eye pressure readings miss risk?

Yes. Eye pressure varies throughout the day and may not always reflect pressure changes during specific activities.

Should musicians undergo glaucoma screening?

Anyone with glaucoma risk factors: including family history, elevated eye pressure, suspicious optic nerves, or age-related risk, should consider regular comprehensive eye examinations.

Can glaucoma affect musicians even if they read music normally?

Yes. Early glaucoma often affects peripheral vision first. Reading music may remain normal while subtle visual field changes develop elsewhere.

What symptoms should musicians watch for?

Glaucoma often causes no symptoms in its early stages. Regular examinations are more reliable than symptom monitoring alone.


Key Takeaway

Playing a wind instrument does not automatically mean you are at risk of glaucoma.

However, research suggests that certain instruments may temporarily increase eye pressure, particularly when substantial resistance is involved.

The relationship is complex. Instrument type, technique, breathing mechanics, eye anatomy, and individual susceptibility all matter.

For musicians with glaucoma or glaucoma risk factors, awareness—not alarm—is the right response.

The goal is not to stop making music.

The goal is to protect vision so that music can remain part of life for years to come.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Note: This article was written by Dr. Shibal Bhartiya, and was updated following correspondence with Professor Emeritus Frank Gabriel Campos regarding brass performance technique.

Why Do I Need Glaucoma Treatment If My Vision Seems Normal?

Glaucoma often causes permanent optic nerve damage long before noticeable vision loss develops. Treatment is designed to protect your future vision by slowing or preventing progression before symptoms appear, Dr Shibal Bhartiya explains.

Your vision feels fine. No pain, no blur, no obvious change. So why is your doctor urging treatment? This is the most common question glaucoma patients ask, and it deserves a direct, honest answer,

Glaucoma destroys your optic nerve silently. By the time you notice something is wrong, you have already lost nerve fibres that will never return. Treatment does not restore what is gone. It protects what remains.


The Vision You Have Now Is Not the Vision You Started With

Glaucoma removes peripheral vision first. Your central vision stays sharp until the disease is advanced. Your brain also compensates, filling in blind areas so skilfully that you do not notice them. You may have lost 30 to 40 percent of your optic nerve fibres before any symptom appears.

This is why “I can see fine” is not a safe reassurance in glaucoma. It reflects the vision that has survived, not the vision that has been lost.


Why Glaucoma Treatment Feels Unnecessary (And Why That Feeling Is Dangerous)

Glaucoma drops do not improve your vision. They do not reduce pain because glaucoma causes none. They do not change how things look today. Their only job is to lower the pressure inside your eye and slow the damage to your optic nerve.

When a treatment produces no felt benefit, stopping it feels harmless. This is the central psychological trap in glaucoma care. Patients who feel well skip doses, delay refills, or discontinue treatment altogether. The nerve continues to deteriorate. By the time symptoms appear, the loss is severe and permanent.

The absence of symptoms is not evidence that you are safe. It is evidence that the disease has not yet crossed your threshold of awareness.


What the Research Actually Shows

Studies consistently show that controlling eye pressure reduces the risk of glaucoma progression. The Ocular Hypertension Treatment Study showed that lowering pressure by 20 percent reduced conversion to glaucoma by more than half. The Early Manifest Glaucoma Trial showed that each mmHg reduction in pressure produced a measurable reduction in progression risk.

You are not treating a feeling. You are treating a measurable biological risk that happens to produce no warning before it causes irreversible harm.


“But My Pressures Are Controlled Now — Do I Still Need Drops?”

Yes. Controlled pressure means the treatment is working. Stopping treatment removes the protection. Pressure typically rises again within days to weeks after discontinuation.

Some patients assume that normal pressure readings mean the problem is resolved. Glaucoma is a chronic condition. Controlled pressure is a maintained state, not a cured one.


Normal-Tension Glaucoma: When Pressure Is Not Even the Full Story

A significant group of patients develop glaucoma with eye pressures in the statistically normal range. Their optic nerves are still vulnerable, often due to poor blood flow, structural susceptibility, or other factors. For these patients, the question “but my pressure is fine” does not mean treatment is unnecessary. It means the target pressure needs to be set lower, and other risk factors need attention.

This is one reason that glaucoma management requires individual assessment, not a one-size guideline.


FAQ

If I have no symptoms, does that mean my glaucoma is mild?

Not necessarily. Glaucoma can cause significant optic nerve damage before any symptom appears. The severity of glaucoma is assessed through structural tests like OCT and functional tests like visual fields, not through how your vision feels day to day.

What happens if I skip my glaucoma drops for a few days?

Eye pressure can rise within 24 to 48 hours of stopping treatment. Over time, this pressure exposure adds to cumulative nerve damage. Occasional missed doses are less harmful than long gaps, but no dose-skipping is risk-free in active glaucoma.

Can I know if my glaucoma is getting worse?

Progression is detected through serial OCT scans and visual field testing, not through symptoms. This is why regular follow-up is essential even when your vision feels unchanged.

My doctor wants to change my drops. Should I get a second opinion first?

A second opinion is always appropriate in glaucoma, especially if you are uncertain about treatment changes, surgical recommendations, or whether your current regimen is adequate. Glaucoma causes irreversible loss, so the cost of a wrong decision is permanent.

Are there people who do not need treatment despite a glaucoma diagnosis?

In very early suspected glaucoma or ocular hypertension with low risk factors, observation may be appropriate rather than immediate treatment. This is a clinical judgement based on your individual risk profile, your optic nerve appearance, and your visual field results. It requires an experienced glaucoma specialist to make that call correctly.


What You Should Expect From Your Glaucoma Care

A good glaucoma consultation does more than prescribe drops. It establishes your target pressure based on your stage of disease, your age, and your life expectancy. Also, it identifies your progression rate through serial testing. It reviews whether your current treatment is achieving that target. And it explains, clearly, what is at stake if treatment is inconsistent.

If you have left a consultation without understanding why your specific pressure target was chosen, that is worth asking about. If you are uncertain whether your glaucoma is stable or progressing, that is worth investigating through formal visual field and OCT trend analysis.


A Note on Seeking a Second Opinion

Glaucoma decisions carry permanent consequences. Second opinions are not a sign of distrust toward your current doctor. They are a rational response to a disease where the cost of under-treatment is irreversible. An independent review of your scans and pressure history can confirm that you are on the right path, or catch something that has been missed.


This page is part of the Glaucoma Hub hub. Read about our full approach to glaucoma care. Please also read our Second Opinion Hub. Please also read Glaucoma Diagnosis, first 90 days; and Glaucoma Treatment

Here’s another heartening patient story: Tired of drops


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google


Glaucoma Diagnosis: First 90 Days

A glaucoma diagnosis can feel overwhelming, but the first 90 days are crucial for understanding your condition, starting treatment, and establishing a plan to protect your vision long term. Early follow-up, regular eye pressure monitoring, and clear communication with your glaucoma specialist can make a significant difference in preserving sight.

Your First 90 Days With Glaucoma: A Step-by-Step Action Plan

Many patients ask me: I have been diagnosed with glaucoma. What do I do now. Here is what I tell them: A glaucoma diagnosis does not mean you are going blind. It means you now have information most people get too late. The next 90 days are the most important window — not because the disease moves fast, but because the habits you build now protect your vision for the next 30 years.

This guide, written by Dr Shibal Bhartiya, tells you exactly what to do, in order.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


Day 1–7 of Glaucoma Diagnosis: Get the Basics Right

Learn to put in your eye drops correctly

This is the single most important skill you will learn. Studies show that over 60% of patients use eye drops incorrectly — and incorrect technique means the drop misses the eye, or drains immediately into the tear duct and does nothing.

Do this:

Wash your hands. Tilt your head back. Pull your lower eyelid gently down to form a pocket. Hold the bottle above the eye without touching it. Squeeze one drop into the pocket — not onto the eyeball directly. Close your eye gently. Press the inner corner of your eye (near the nose) firmly with one finger for 60 seconds. This blocks the tear duct and keeps the drug in the eye where it belongs. Do not blink vigorously. Do not wipe.

If you use more than one drop type, wait five minutes between them. The first drop dilutes and flushes out the second if you use them together.

Ask your doctor or optometrist to watch you do it once. Ask for a correction if your technique needs adjustment.

Here’s a video demostration:

Set your alarms — and take them seriously

Glaucoma drops work only when taken on time, every day, for life. A single missed day matters less than a pattern of casual delays.

Most drops are once daily, ideally at night. Set a recurring alarm on your phone with a label — “Left eye drop, right eye drop, press corner.” Place the bottle next to your toothbrush. The habit links to the existing habit.

If you use drops twice daily, set both alarms. Never rely on memory alone.

File your papers before they disappear

You walked out of the clinic with reports. Photograph or scan every one of them today — the visual field test, the OCT nerve scan, the IOP readings, the prescription. Put them in a dedicated folder on your phone or email them to yourself with the subject line “Glaucoma Records — [your name].”

You will need these at your next visit, at any second opinion, and if you travel and need emergency eye care. Doctors cannot make good decisions without your baseline.


Week 2–4 of Glaucoma Diagnosis: Build the Follow-Up Structure

Your 30-day appointment is not optional

Glaucoma drops take four to six weeks to show their full pressure-lowering effect. Your doctor needs to see you at 30 days to measure whether the drop is working — and to catch side effects early. Do not skip this.

At this visit, your doctor will check:

  • Your intraocular pressure (IOP) against your baseline
  • Whether the drop is causing redness, allergy, or discomfort
  • Whether you need a dose adjustment or a switch to a different medication

Set a calendar reminder for this appointment the day you are diagnosed. If the appointment was not scheduled, call the clinic and schedule it yourself before the week is over.

Know what side effects to watch for

Most glaucoma drops are well-tolerated. But some cause changes you should know about.

Prostaglandin analogues (bimatoprost, travoprost, latanoprost) can darken the iris over time in some patients, and may cause eyelash growth or mild redness. These are cosmetic and not dangerous — but tell your doctor.

Beta-blockers (timolol) can slow your heart rate and cause breathlessness in patients with asthma or heart disease. If you feel unusually short of breath or very tired after starting drops, contact your doctor the same day.

Alpha agonists (brimonidine) sometimes cause an allergic reaction with marked redness and discharge, usually within weeks of starting. Stop the drop and call your doctor if this happens.

None of these mean you must stop treatment. They mean the treatment may need adjustment.


Month 1–2 of Glaucoma Diagnosis: Tell Your Family

Your siblings and children need an eye check — now

Glaucoma has a strong genetic component. First-degree relatives of a glaucoma patient have a four to nine times higher risk of developing the disease. Most of them will have no symptoms at all until damage is advanced.

Tell your siblings and adult children this week. Ask them to see an ophthalmologist for a baseline pressure check, optic nerve assessment, and field test. This is not alarmist. It is the most useful thing your diagnosis can do for your family.


Month 1–3: Address the Controllable Risk Factors

Stop smoking — this one is not negotiable

Smoking constricts blood vessels and reduces blood flow to the optic nerve. It worsens the vascular risk that many glaucoma patients already carry. The damage from smoking adds to the damage from pressure — and your nerve cannot absorb both.

If you smoke, speak to your doctor about cessation support. This is as important as the drops.

Get your metabolic parameters checked

High blood pressure, diabetes, thyroid disease, and sleep apnoea all affect glaucoma progression through vascular and metabolic pathways. If these are uncontrolled, your optic nerve faces risk from two directions simultaneously.

Ask your physician to check your blood pressure, fasting glucose, HbA1c, and thyroid function if these have not been done recently. If you snore heavily or feel exhausted in the mornings, mention it — untreated sleep apnoea is a recognised glaucoma risk factor that is almost always missed.

Exercise — the right kind

Moderate aerobic exercise (brisk walking 30 minutes, five days a week) lowers intraocular pressure by a clinically meaningful amount in most patients. Avoid high-resistance head-down exercises like heavy weightlifting or inverted yoga poses — these transiently spike IOP.


Month 2–3: Ask About Laser Treatment

SLT — Selective Laser Trabeculoplasty

If your glaucoma is open-angle type, your doctor may recommend SLT as a first-line treatment or as a supplement to drops. SLT uses a laser to improve fluid drainage from the eye. It is done in the clinic in five to ten minutes, is painless, and works in approximately 75 to 80% of patients.

The effect lasts three to five years and can be repeated. SLT does not burn tissue — it sends a gentle energy pulse that stimulates the drainage cells to work better.

Ask your doctor at the 30-day or 90-day visit: “Am I a candidate for SLT?”

LPI — Laser Peripheral Iridotomy

If your glaucoma is narrow-angle or angle-closure type, LPI is a preventive procedure that creates a small opening in the iris to prevent a sudden pressure spike (acute angle-closure attack). LPI is typically recommended before an attack happens — it takes three to four minutes per eye and prevents one of the most painful ophthalmic emergencies.

If your doctor mentioned narrow angles at any point, ask specifically whether you need LPI. Do not wait.


Throughout: Keep Your Perspective

Do not search the internet at 2am

Glaucoma outcomes in treated patients are overwhelmingly good. The disease moves slowly in the vast majority of cases. Patients who take their drops, attend follow-ups, and manage their risk factors maintain useful vision for life in most cases.

The stories of severe vision loss you will find online mostly involve patients who were never diagnosed, or who stopped treatment. You are neither.

Reach out if you need support

A new diagnosis changes how you think about your body. Some patients find this unsettling, and that is entirely normal. Several Indian and international glaucoma patient forums, and online communities run by ophthalmologists offer peer support from people at every stage of the same journey.

You do not have to figure this out alone.


Your 90-Day Checklist

  • Eye drop technique confirmed by a doctor or technician
  • Alarm set — every day, same time
  • All reports photographed and filed digitally
  • 30-day follow-up appointment booked
  • Side effects list saved on your phone
  • Siblings and adult children informed and booked for screening
  • Smoking cessation initiated if applicable
  • Blood pressure, glucose, HbA1c, thyroid checked
  • SLT or LPI discussion had with your doctor
  • One support resource bookmarked

Frequently Asked Questions

Do I have to take eye drops for life?

In most cases, yes. Glaucoma is a chronic condition and eye drops control pressure — they do not cure the disease. Stopping drops allows pressure to rise again and damage to resume. Some patients reduce or stop drops after successful laser treatment (SLT), but this is a decision made with your doctor based on your pressure readings, not independently.

What if I forget a drop one day?

Take it as soon as you remember, unless it is almost time for the next dose. Do not double up. One missed dose will not cause a crisis. A habit of casual misses will. Reset the alarm and continue.

Can I drive after putting in my eye drops?

Most glaucoma drops do not affect vision significantly. Some patients notice mild blurring for a few minutes immediately after instillation — wait for this to clear before driving. If your doctor has dilated your pupils at a clinic visit, do not drive until dilation wears off, typically three to four hours.

My pressure was normal at diagnosis. Do I still have glaucoma?

Yes — this is called normal-tension glaucoma (NTG). Roughly 30 to 40% of glaucoma patients in India have pressures within the statistical normal range. The diagnosis is made on optic nerve appearance and visual field changes, not pressure alone. NTG is treated the same way — the target is to lower pressure further from your individual baseline.

Is glaucoma hereditary? Do I need to tell my family?

Yes, and yes. First-degree relatives — parents, siblings, children — have a four to nine times higher risk. Most will have no symptoms. Tell them this week and ask them to see an ophthalmologist for a baseline check that includes pressure, nerve assessment, and a visual field test.

Will I go blind?

Treated glaucoma in a compliant patient who attends follow-up carries a very low risk of blindness. The risk is real only when the disease is undiagnosed, undertreated, or ignored. You have been diagnosed. That is the most important step already taken.

What is SLT and should I ask about it?

Selective Laser Trabeculoplasty (SLT) is a five-minute clinic procedure that improves fluid drainage from the eye. It works in approximately 75 to 80% of open-angle glaucoma patients and can reduce or eliminate the need for drops for three to five years. Ask your doctor at the 30-day visit whether you are a candidate.

Can I exercise with glaucoma?

Yes — moderate aerobic exercise is actively beneficial and lowers IOP. Brisk walking, cycling, and swimming are all good. Avoid heavy resistance training with breath-holding (Valsalva manoeuvre) and inverted positions, both of which spike pressure transiently. If exercise is a regular part of your routine, tell your doctor so they can factor it into your pressure readings.

My drops are making my eyes red. Should I stop?

Do not stop without speaking to your doctor first. Redness is common with several drop classes and is often manageable — a preservative-free formulation or a switch in medication resolves it in most cases. Stopping drops independently allows pressure to rise. Call the clinic and describe the symptom.

How often will I need follow-up forever?

Once stable on treatment, most patients are reviewed every three to six months. This includes a pressure check and, once yearly or more often if needed, a repeat visual field test and OCT nerve scan to confirm the disease is not progressing. Glaucoma never becomes self-managing — the follow-up rhythm continues for life, but it is not onerous once the initial titration phase is complete.


This page is part of the Glaucoma Hub hub. Read about our full approach to glaucoma care and monitoring. Please also read our guide to Understanding Your Visual Field Test. You may want to read a patient’s experience with glaucoma eye drops, and of one with SLT.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google


Travelling To India for Eye Care

Travelling to India for eye treatment? Travel for medical care is not simply about finding treatment. It is about finding the right diagnosis, understanding your options, and making important decisions with confidence. Dr Shibal Bhartiya provides specialist eye care for international patients seeking expert evaluation, second opinions, advanced diagnostics, and long-term management of complex eye conditions.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Expert Eye Care in India for Patients Seeking Clarity, Confidence, and Specialist Opinion

GlaucomaNeuro-OphthalmologyDry Eye & Ocular Surface DiseaseComplex Eye Care

Patients travel from the UK, USA, UAE, Singapore, Bangladesh, Nepal, East Africa, and across South Asia for consultations focused on careful assessment, evidence-based recommendations, and clear communication.

25+ Years Experience | 200+ Publications | 28 Textbooks | 1,500+ Five-Star Reviews | International Patients from 20+ Countries | 40000+ patients


Why International Patients Choose Dr Shibal Bhartiya

A Specialist Perspective for Complex Problems

Many patients seeking international consultations are not looking for another routine eye examination.

They are seeking answers to questions such as:

  • Am I actually progressing?
  • Do I really need surgery?
  • Why do my symptoms not match my test results?
  • Has something important been missed?
  • Why am I still struggling despite treatment?
  • Should I seek a second opinion before making a major decision?

Our consultations are designed to answer these questions through detailed evaluation, advanced diagnostics, and careful clinical interpretation.


Areas of Special Expertise

Glaucoma

Glaucoma is often diagnosed late because patients may continue seeing well while irreversible damage accumulates silently.

Dr Bhartiya’s glaucoma practice focuses on:

  • Early glaucoma diagnosis
  • Glaucoma suspects and risk assessment
  • Progression analysis
  • Normal tension glaucoma
  • Complex glaucoma management
  • Surgical decision-making
  • Second opinions before surgery
  • Long-term vision preservation strategies

Many international patients seek consultation after receiving conflicting advice or when they are uncertain whether treatment escalation is truly necessary.

You can read more about glaucoma here


Neuro-Ophthalmology

Neuro-ophthalmology bridges the gap between ophthalmology and neurology.

Common reasons for referral include:

  • Optic nerve disorders
  • Unexplained visual loss
  • Visual field abnormalities
  • Pituitary-related visual problems
  • Double vision
  • Intracranial hypertension
  • Neurological causes of visual symptoms
  • Complex diagnostic uncertainty

Patients are often referred after multiple consultations when symptoms, scans, and examinations do not fit together neatly.

You can read more about neuro-ophthalmology care here


Dry Eye & Ocular Surface Disease

Many patients with ocular surface disease have been treated repeatedly without understanding the underlying drivers of their symptoms.

Areas of focus include:

  • Chronic dry eye disease
  • Meibomian gland dysfunction
  • Ocular surface inflammation
  • Computer-related eye strain
  • Autoimmune ocular surface disease
  • Refractory dry eye
  • Ocular GVHD
  • Complex ocular discomfort syndromes

The goal is not simply prescribing more drops, but understanding why symptoms persist.

You can read more about ocular surface diseases including dry eye, and allergies, here


Comprehensive Ophthalmology & Diagnostic Second Opinions

Not every patient arrives with a diagnosis.

Many simply know that something is wrong.

We frequently evaluate patients seeking answers regarding:

  • Unexplained visual symptoms
  • Diagnostic uncertainty
  • Cataract and glaucoma overlap
  • Complex treatment decisions
  • Risk assessment before intervention
  • Long-term monitoring plans

Explore Our Specialist Eye Care Services

International patients often arrive with a diagnosis, a recommendation, or simply a concern that something is being missed.

While glaucoma, neuro-ophthalmology, and ocular surface disease are areas of particular expertise, every patient journey is different. Explore our specialist services below to better understand your condition and the options available.

Glaucoma Care

Glaucoma can cause permanent vision loss before symptoms become obvious. Learn about glaucoma diagnosis, risk assessment, progression monitoring, treatment options, and specialist second opinions.

Explore Glaucoma Care →


Neuro-Ophthalmology

Visual symptoms are not always caused by the eye itself. Neuro-ophthalmology evaluates disorders affecting the optic nerve, visual pathways, eye movements, and the connection between the eye and brain.

Explore Neuro-Ophthalmology →


Dry Eye & Ocular Surface Disease

Persistent irritation, burning, watering, fluctuating vision, and discomfort often require a deeper evaluation than routine eye examinations provide. Learn more about dry eye disease, meibomian gland dysfunction, ocular GVHD, and ocular surface disorders.

Explore Dry Eye & Ocular Surface Disease →


Second Opinions

Many patients seek reassurance before surgery, treatment escalation, or major decisions. A specialist second opinion can provide clarity, confirm a diagnosis, or identify alternative approaches.

Explore Second Opinions →


Advanced Diagnostic Testing

Accurate diagnosis depends on more than a single test result. Learn how OCT imaging, visual field analysis, optic nerve evaluation, and ocular surface assessment contribute to clinical decision-making.

Explore Advanced Diagnostics →


Comprehensive Eye Care

Not every patient arrives with a diagnosis. Some simply know that their vision has changed or that something does not feel right. Explore common eye conditions, symptoms, and specialist evaluation pathways.

Explore Comprehensive Eye Care →

Whether you are seeking a second opinion, treatment recommendations, or answers to a complex diagnostic question, our goal is to help you understand your condition clearly and make confident decisions about your eye health.

Popular Searches: glaucoma specialist India, neuro-ophthalmologist India, dry eye specialist India, glaucoma second opinion India, ocular surface disease specialist India, international eye specialist India, advanced eye care India, ophthalmologist for international patients.


International Patient Journey

Step 1: Send Your Records

Before travelling, patients may share:

  • Previous consultation notes
  • OCT scans
  • Visual field reports
  • MRI or CT reports
  • Surgical recommendations
  • Current medication lists

This allows preliminary review and helps ensure efficient use of consultation time.


Step 2: Pre-Visit Review

Records are reviewed before your appointment whenever possible.

This means consultations begin with context rather than starting from zero.


Step 3: Specialist Evaluation

Consultations may include:

  • Comprehensive examination
  • Advanced imaging
  • Functional testing
  • Risk assessment
  • Discussion of treatment options
  • Clarification of previous findings

Most investigations can be completed in a single visit.


Step 4: Written Clinical Opinion

Patients receive:

  • Detailed findings
  • Interpretation of investigations
  • Diagnosis (where possible)
  • Treatment recommendations
  • Follow-up strategy

Reports can be shared with treating doctors in the patient’s home country to support continuity of care.


Step 5: Ongoing Follow-Up

Many eye conditions require continuity rather than isolated intervention.

Where appropriate, follow-up planning may include:

  • Remote review of reports
  • Communication with local specialists
  • Monitoring recommendations
  • Long-term management planning

Why Patients Travel to India

India offers access to:

  • Advanced ophthalmic diagnostics
  • Internationally recognised specialists
  • Minimal waiting times
  • Comprehensive investigations in one location
  • Cost-effective care compared with many Western healthcare systems

Many patients are able to complete evaluation and decision-making within a short visit.


About Dr Shibal Bhartiya

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist with over 25 years of clinical experience. Her work combines clinical care, research, education, and international collaboration.

Highlights include:

  • Fellowship-Trained Glaucoma Specialist
  • Mayo Clinic Research Collaborator
  • 200+ Scientific Publications
  • 90+ PubMed-Indexed Papers
  • 28 Edited Textbooks
  • Editor-in-Chief, CLEVER
  • Executive Editor, Journal of Current Glaucoma Practice
  • International Speaker and Research Collaborator

Languages Spoken

To make complex medical discussions easier for international patients, consultations may be conducted with an interpreter, or facilitator if required. However, Dr Shibal Bhartiya speaks several languages:

  • English
  • Hindi
  • Urdu
  • French
  • Bangla (conversational)
  • Arabic (basic conversational)
  • Persian / Farsi (basic conversational)

Medical records and formal clinical documentation are provided in English, and may be provided in Hindi, French or Urdu on request .


Frequently Asked Questions

Can I send my reports before travelling?

Yes. Sharing reports beforehand helps determine what additional testing may be needed and allows more focused consultations.

Can I obtain a second opinion without surgery?

Absolutely. A large proportion of international patients seek clarity and confirmation before making treatment decisions.

How long should I stay in India?

Most second-opinion evaluations can be completed within 2–3 days. Surgical patients may require longer depending on the procedure.

Will my doctor at home receive a report?

Yes. With your permission, a detailed written opinion can be shared with your treating physician.

Do you assist with medical visa documentation?

Supporting medical documentation can be provided where required.


Send Your Reports Before You Travel

If you are considering travelling to India for glaucoma, neuro-ophthalmology, dry eye treatment, or a specialist second opinion, the process can begin before you leave home.

Send your reports, scans, or questions for review.

Dr Shibal Bhartiya
Glaucoma • Neuro-Ophthalmology • Advanced Eye Care • Second Opinion

🌐 www.drshibalbhartiya.com
📞 +91 88826 38735


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Are steroid eye drops dangerous?

Steroid eye drops prescribed by a doctor are not dangerous. They become dangerous when used without a prescription, unsupervised, or for longer than directed, because they may increase your eye pressure. This puts you at risk for steroid induced glaucoma. But when your doctor prescribes them, the benefit — stopping inflammation, saving vision — outweighs the risk. Avoiding a necessary prescription is where real harm begins, explains Dr Shibal Bhartiya.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Steroids in the Eye: When Fear of the Drop Does More Damage

She was a psychiatrist. A trained physician. She understood pharmacology, and she had read about intraocular pressure and steroid response. So when her ophthalmologist prescribed steroid eye drops after an adenoviral conjunctivitis, she quietly decided not to use them.

Three months later, she sat in front of me. A psychiatrist — a trained physician — spent three months losing vision because she was afraid to use a prescribed drop. Here is what that case teaches every patient.

Her vision had dropped to 6/18 in both eyes. Her corneas were covered in superficial punctate keratitis — so dense and widespread it looked almost like numular keratitis. What began as a straightforward viral conjunctivitis had become a prolonged, damaging inflammatory response, because her immune system was never asked to stand down.

She had never had her eye pressure checked, and was not a known steroid responder. She had simply been afraid of a word.

Within three to four days of starting the prescribed drops, she began to improve. Her vision normalised in two weeks. Three months of avoidable suffering — from one decision to skip a prescription. Her pressures remained well within normal limits.

Why the Fear Exists — and the Risk

Steroids raise eye pressure in susceptible individuals. This is true. In long-term, unsupervised use, the kind that happens when people buy steroid drops over the counter, this risk is real and serious. Steroid Induced Glaucoma can cause irreversible vision loss.

But this is not the situation your doctor creates when they hand you a prescription. She will check your eye pressures before starting eye drops, and monitor it through the duration of therapy.

A doctor prescribing steroid drops accounts for:

  • The specific diagnosis — inflammation, allergy, or a post-viral immune response
  • The right steroid molecule and strength for that condition
  • A taper plan, not an open-ended course
  • Pressure monitoring if the course extends beyond the short term

The risk of not using the drops, in the right condition, is often far greater than any monitored, time-limited course.

Important

In India, steroid eye drops can be purchased without a prescription. This does not make it safe. Unsupervised, over-the-counter steroid use is the primary source of steroid-related eye damage: not prescribed, monitored courses. The two situations carry entirely different risk profiles.

To know more about glaucoma, risks and symptoms, you may want to listen to this conversation

VKC in Children: Where Hesitation Costs Sight

Parents of children with vernal keratoconjunctivitis (VKC) frequently arrive distressed at the idea of steroids for their child. The concern is understandable. It is also, when correctly informed, less alarming than the disease itself.

Fluorometholone and loteprednol are approved for children as young as one year in the United States. These are not aggressive systemic steroids. They are targeted molecules with well-established paediatric safety records, prescribed precisely because the risks of the disease exceed the risks of the treatment.

Giant papillary conjunctivitis does not respond to antiallergic drops alone. Corneal shields (or shield ulcers) — the plaques that form in severe VKC — do not respond to cold compresses, and mild anti allergies. The window for preventing permanent corneal damage is not infinite.

In these cases, the right medicine at the right time, under supervision, is the difference between a child who sees normally and one who does not.

Steroid Eye Drops at a Glance

Molecules, indications, risk by scenario, and cost of avoidance — combined reference

Steroid / ScenarioCommon UseApproved AgeSupervised RiskUnsupervised / OTC RiskCost of Avoidance
Steroid Molecules
Prednisolone acetateSevere inflammation, post-surgical, uveitisAdults (caution in children)Moderate
Higher IOP risk; needs monitoring
High
Glaucoma, cataract risk
Corneal scarring, vision loss
Fluorometholone (FML)Allergic conjunctivitis, VKC, mild-moderate inflammation≥ 2 years (US approval)Lower
Reduced IOP penetration
Moderate
Still causes pressure rise if prolonged
Persistent giant papillae, corneal shield
LoteprednolVKC, seasonal allergy, post-surgical≥ 1 year (US approval)Low
Metabolised locally; lowest IOP burden
Moderate
Risk increases with duration
Persistent severe allergy, corneal damage
DexamethasoneSevere ocular inflammation, post-op, uveitisAdults; children under specialist careModerate–High
Strong molecule; close monitoring needed
Very High
Rapid IOP rise possible
Irreversible optic nerve damage if pressure unchecked
Clinical Scenarios
Post-viral keratitis (adenoviral)Subepithelial infiltrates, SPK, vision dropAll agesLow–Moderate
Short course, tapered
High
Prolonged use → pressure crisis
Persistent SPKs, 6/18 or worse vision — as seen in case above
VKC (children)Giant papillae, shield ulcer risk, corneal involvementAs young as 1 year with appropriate moleculeLow
With loteprednol / FML and monitoring
High
Inappropriate molecule + no monitoring
Corneal shield ulcer, permanent visual impairment
Giant papillary conjunctivitisSevere allergic response, contact lens–relatedAdults and older childrenLow–Moderate
Under supervision
ModerateNo response to antiallergics alone; chronic discomfort, corneal involvement
Use Pattern Risk
Prescribed short course (7–14 days, tapered)Any indicated conditionLowN/A — by definition supervisedAvoidance causes disease progression
OTC self-medication, IndiaOften misused for red eye, irritationN/AVery High
No diagnosis, no taper, no monitoring
Steroid-induced glaucoma, cataract — often irreversible

What You Should — and Should Not — Do

Use steroid eye drops when your doctor prescribes them. Follow the taper exactly. Do not stop abruptly. Have your pressure checked if your doctor asks. Do not extend the course on your own judgment.

Do not buy steroid eye drops from a pharmacy without a prescription. In India, this is possible. It is also the origin of most steroid-related eye complications seen in clinical practice — not prescribed, monitored use.

Frequently Asked Questions

Can steroid eye drops damage my eyes?

Steroid eye drops used without medical supervision, and for longer than prescribed, can raise eye pressure, cause cataracts, and increase infection risk. Prescribed, monitored courses carry a very different risk profile. The damage in most cases comes from unsupervised, over-the-counter use — not from following a doctor’s prescription.

Why did my doctor prescribe steroid drops after conjunctivitis?

After viral conjunctivitis — particularly adenoviral — the eye can mount a prolonged inflammatory response even after the infection clears. Steroid drops are prescribed to control this immune response and protect the cornea. Skipping them does not protect you. It leaves the inflammation unchecked.

Are steroid eye drops safe for children with VKC?

Specific steroid molecules — fluorometholone, loteprednol — are approved for use in young children and have an established paediatric safety record. In vernal keratoconjunctivitis, the risk of corneal damage from untreated disease is often greater than the risk from a supervised steroid course.

Can I buy steroid eye drops without a prescription in India?

Unscrupulous pharmacies in India dispense them without a prescription. This does not mean it is safe. Unsupervised steroid use is the primary cause of steroid-related eye complications. Always use them under a doctor’s direction.

What is a steroid responder?

Some individuals — roughly 5% of the population — show a significant rise in eye pressure in response to steroid drops. This is a genetic predisposition. It does not mean everyone should avoid steroids; it means a doctor prescribing steroids should check your pressure during use, particularly if the course extends beyond two weeks.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google